↓ Skip to main content

Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy

Overview of attention for article published in Breast Cancer Research, April 2015
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

policy
1 policy source
twitter
2 X users
facebook
2 Facebook pages

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
84 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy
Published in
Breast Cancer Research, April 2015
DOI 10.1186/s13058-015-0568-1
Pubmed ID
Authors

Kathrin Strasser-Weippl, Nora Horick, Ian E Smith, Joyce O’Shaughnessy, Bent Ejlertsen, Frances Boyle, Aman U Buzdar, Pierre Fumoleau, William Gradishar, Miguel Martin, Beverly Moy, Martine Piccart-Gebhart, Kathleen I Pritchard, Deborah Lindquist, Erica Rappold, Dianne M Finkelstein, Paul E Goss

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 84 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Colombia 1 1%
Denmark 1 1%
Unknown 81 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 18 21%
Other 13 15%
Student > Bachelor 8 10%
Student > Master 7 8%
Student > Ph. D. Student 6 7%
Other 11 13%
Unknown 21 25%
Readers by discipline Count As %
Medicine and Dentistry 22 26%
Biochemistry, Genetics and Molecular Biology 11 13%
Agricultural and Biological Sciences 8 10%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Nursing and Health Professions 3 4%
Other 12 14%
Unknown 24 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 June 2018.
All research outputs
#6,753,240
of 25,371,288 outputs
Outputs from Breast Cancer Research
#771
of 2,052 outputs
Outputs of similar age
#69,787
of 262,385 outputs
Outputs of similar age from Breast Cancer Research
#17
of 43 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 2,052 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 262,385 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.